Latest News about PFE
Recent news which mentions PFE
From Benzinga
Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower
December 01, 2023
From Benzinga
This Twice Daily Weight Loss Drug Has Adverse Side Effects And Pfizer Wants To Discontinue It
December 01, 2023
Tickers
PFE
From Benzinga
From MarketWatch
Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love
November 30, 2023
From InvestorPlace
3 Synthetic Biology Stocks Likely to Mint New Millionaires
November 29, 2023
From InvestorPlace
Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's
November 28, 2023
From Benzinga
Investors beware: ‘Magnificent Seven’ are starting to resemble ‘Nifty 50’ stocks that got crushed in the 1970s market crash
November 28, 2023
From MarketWatch
SpringWorks Therapeutics’ stock jumps after FDA approves first treatment for rare type of aggressive tumors
November 28, 2023
From MarketWatch
From MarketWatch
3 Top-Rated Value Stocks That Analysts Are Loving Now
November 27, 2023
From InvestorPlace
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
November 27, 2023
From Benzinga
From Motley Fool
2 Stocks You'll Be Grateful You Bought at These Bargain Prices
November 22, 2023
From Motley Fool
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
November 21, 2023
From Benzinga
From Benzinga
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
November 21, 2023
From Motley Fool
These ten stocks, not just from tech, are the key to next year’s S&P 500 earnings growth
November 21, 2023
From MarketWatch
Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth
November 20, 2023
From InvestorPlace
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
November 20, 2023
From Benzinga
From Benzinga
Medicare’s exclusion of weight-loss drug coverage under fire
November 20, 2023
From MarketWatch
The stock market has rallied 63 times after a correction. Why this time is different, says Deutsche Bank.
November 20, 2023
From MarketWatch
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
November 20, 2023
From MarketWatch
The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023
November 19, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.